PITUITARY AND HYPOTHALAMIC SOMATOSTATIN RECEPTOR SUBTYPE MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN THE FOOD-DEPRIVED AND DIABETIC RAT

被引:41
作者
BRUNO, JF [1 ]
XU, Y [1 ]
SONG, JF [1 ]
BERELOWITZ, M [1 ]
机构
[1] SUNY STONY BROOK,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794
关键词
D O I
10.1210/en.135.5.1787
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolonged food deprivation (FD) and streptozocin-induced diabetes (STZ diabetes) in the rat result in abolition of GH secretory episodes. We have previously shown that hypothalamic prepro-GRF messenger RNA (mRNA) expression is markedly reduced in the hypothalamus of FD and STZ diabetic rats, with no change in prepro-somatostatin (SRIF) mRNA and suggested that reduced GRF and increased SRIF tone explained the loss of GH secretion in FD and STZ diabetes. Altered SRIF peptide expression has been implicated in many physiological and pathological states; however, information on the regulation of SRIF receptor (SSTR) expression is lacking. Therefore, we examined the expression of mRNA for the five recently cloned SSTR subtypes in the pituitary and hypothalamus of FD and STZ diabetic rats. In addition, we measured SRIF binding to pituitary membranes of FD rats. SSTR1, SSTR2, and SSTR3 mRNA expression was reduced 80% in the pituitary of FD rats vs, fed controls, whereas pituitary levels of SSTR4 and SSTR5 mRNA were unaffected. The pituitary plasma membrane SSTR concentration was reduced over 50% in FD us. fed animals. However, hypothalamic levels of the five isoforms were unchanged. In STZ diabetes, pituitary SSTR1, SSTR2, and SSTR3 mRNA expression was reduced 50-80%, with levels of SSTR1 partially restored by insulin, whereas SSTR4 mRNA was unchanged. In contrast to the effect of FD, SSTR5 mRNA levels were reduced 70% in the pituitary and 30% in the hypothalamus of STZ diabetic rats, with complete restoration by insulin. Thus, SSTR subtype mRNA expression is differentially regulated in two models of GH deficiency in the rat, FD and STZ diabetes. As chronic exposure to SRIF results in desensitization of transfected SSTR2 and SSTR3, and SSTR binding is decreased in FD and STZ diabetic rats, the possibility exists that the pituitary changes result from continued exposure to SRIF. In the hypothalamus, however, regulation appears more complex. These data support a role of increased SRIF with decreased GRF in mediating the loss of GH secretion in FD and diabetes.
引用
收藏
页码:1787 / 1792
页数:6
相关论文
共 36 条
  • [11] INVOLVEMENT OF CENTRAL SOMATOSTATIN IN THE ALTERATION OF GH SECRETION IN STARVED RATS
    MOUNIER, F
    BLUETPAJOT, MT
    DURAND, D
    KORDON, C
    RASOLONJANAHARY, R
    EPELBAUM, J
    [J]. HORMONE RESEARCH, 1989, 31 (5-6) : 266 - 270
  • [12] OCARROLL AM, 1992, MOL PHARMACOL, V42, P939
  • [13] ALTERED PITUITARY GROWTH-HORMONE (GH) REGULATION IN STREPTOZOTOCIN-DIABETIC RATS - A COMBINED DEFECT OF HYPOTHALAMIC SOMATOSTATIN AND GH-RELEASING FACTOR
    OLCHOVSKY, D
    BRUNO, JF
    WOOD, TL
    GELATO, MC
    LEIDY, JW
    GILBERT, JM
    BERELOWITZ, M
    [J]. ENDOCRINOLOGY, 1990, 126 (01) : 53 - 61
  • [14] CHANGES IN SOMATOSTATIN CONCENTRATION IN PANCREAS AND OTHER TISSUES OF STREPTOZOTOCIN DIABETIC RATS
    PATEL, YC
    CAMERON, DP
    BANKIER, A
    MALAISSELAGAE, F
    RAVAZZOLA, M
    STUDER, P
    ORCI, L
    [J]. ENDOCRINOLOGY, 1978, 103 (03) : 917 - 923
  • [15] MECHANISM OF ACTION OF SOMATOSTATIN - AN OVERVIEW OF RECEPTOR FUNCTION AND STUDIES OF THE MOLECULAR CHARACTERIZATION AND PURIFICATION OF SOMATOSTATIN RECEPTOR PROTEINS
    PATEL, YC
    MURTHY, KK
    ESCHER, EE
    BANVILLE, D
    SPIESS, J
    SRIKANT, CB
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (09): : 63 - 69
  • [16] INCREASED BLOOD SOMATOSTATIN CONCENTRATION IN STREPTOZOTOCIN DIABETIC RATS
    PATEL, YC
    WHEATLEY, T
    ZINGG, HH
    [J]. LIFE SCIENCES, 1980, 27 (17) : 1563 - 1570
  • [17] PATTERNS OF GROWTH-HORMONE RELEASING-FACTOR AND SOMATOSTATIN SECRETION INTO THE HYPOPHYSIAL-PORTAL CIRCULATION OF THE RAT
    PLOTSKY, PM
    VALE, W
    [J]. SCIENCE, 1985, 230 (4724) : 461 - 463
  • [18] RAYNOR K, 1993, MOL PHARMACOL, V43, P838
  • [19] REISINE T, 1985, J PHARMACOL EXP THER, V229, P14
  • [20] RENSDOMIANO S, 1992, MOL PHARMACOL, V42, P28